Ourania Tatsis Insider Trading for May 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Ourania Tatsis.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of Ourania Tatsis for May 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Sell | S | 288.38 | 9 | 2,595 | 12,738 | 12.7 K to 12.7 K (-0.07 %) |
| May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Sell | S | 287.61 | 33 | 9,491 | 12,747 | 12.8 K to 12.7 K (-0.26 %) |
| May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Sell | S | 286.12 | 20 | 5,722 | 12,780 | 12.8 K to 12.8 K (-0.16 %) |
| May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Sell | S | 284.30 | 10 | 2,843 | 12,800 | 12.8 K to 12.8 K (-0.08 %) |
| May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Sell | S | 281.23 | 21 | 5,906 | 12,810 | 12.8 K to 12.8 K (-0.16 %) |
| May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Sell | S | 279.93 | 17 | 4,759 | 12,831 | 12.8 K to 12.8 K (-0.13 %) |
| May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Sell | S | 276.35 | 10 | 2,764 | 12,848 | 12.9 K to 12.8 K (-0.08 %) |
| May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Option Exercise | M | 155.57 | 407 | 63,317 | 2,854 | |
| May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Option Exercise | M | 187.53 | 559 | 104,829 | 6,145 | |
| May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Sell | S | 275.30 | 30 | 8,259 | 12,738 | 12.8 K to 12.7 K (-0.23 %) |
| May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Sell | S | 274.13 | 330 | 90,463 | 12,768 | 13.1 K to 12.8 K (-2.52 %) |
| May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Sell | S | 273.15 | 210 | 57,362 | 13,098 | 13.3 K to 13.1 K (-1.58 %) |
| May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Sell | S | 272.09 | 217 | 59,044 | 13,308 | 13.5 K to 13.3 K (-1.60 %) |
| May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Sell | S | 270.19 | 136 | 36,746 | 13,525 | 13.7 K to 13.5 K (-1.00 %) |
| May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Sell | S | 268.80 | 43 | 11,558 | 13,661 | 13.7 K to 13.7 K (-0.31 %) |
| May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Buy | M | 155.57 | 407 | 63,317 | 13,704 | 13.3 K to 13.7 K (+3.06 %) |
| May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Buy | M | 187.53 | 559 | 104,829 | 13,297 | 12.7 K to 13.3 K (+4.39 %) |